Heat shock factor 1 (HSF1) specifically potentiates c-MYC-mediated transcription independently of the canonical heat shock response.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
27 06 2023
Historique:
received: 19 09 2022
revised: 27 03 2023
accepted: 08 05 2023
medline: 4 10 2023
pubmed: 24 5 2023
entrez: 24 5 2023
Statut: ppublish

Résumé

Despite its pivotal roles in biology, how the transcriptional activity of c-MYC is tuned quantitatively remains poorly defined. Here, we show that heat shock factor 1 (HSF1), the master transcriptional regulator of the heat shock response, acts as a prime modifier of the c-MYC-mediated transcription. HSF1 deficiency diminishes c-MYC DNA binding and dampens its transcriptional activity genome wide. Mechanistically, c-MYC, MAX, and HSF1 assemble into a transcription factor complex on genomic DNAs, and surprisingly, the DNA binding of HSF1 is dispensable. Instead, HSF1 physically recruits the histone acetyltransferase general control nonderepressible 5 (GCN5), promoting histone acetylation and augmenting c-MYC transcriptional activity. Thus, we find that HSF1 specifically potentiates the c-MYC-mediated transcription, discrete from its canonical role in countering proteotoxic stress. Importantly, this mechanism of action engenders two distinct c-MYC activation states, primary and advanced, which may be important to accommodate diverse physiological and pathological conditions.

Identifiants

pubmed: 37224019
pii: S2211-1247(23)00568-5
doi: 10.1016/j.celrep.2023.112557
pmc: PMC10592515
mid: NIHMS1912767
pii:
doi:

Substances chimiques

DNA 9007-49-2
DNA-Binding Proteins 0
Heat Shock Transcription Factors 0
Proto-Oncogene Proteins c-myc 0
Transcription Factors 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

112557

Subventions

Organisme : NIH HHS
ID : DP2 OD007070
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA BC011767
Pays : United States

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Cell. 2012 Aug 3;150(3):549-62
pubmed: 22863008
Semin Cancer Biol. 2006 Aug;16(4):318-30
pubmed: 16934487
Cancer Cell. 2019 Nov 11;36(5):483-497.e15
pubmed: 31679823
Commun Biol. 2020 Jan 3;3:8
pubmed: 31909200
Clin Cancer Res. 2018 May 15;24(10):2395-2407
pubmed: 29391353
Mol Cell. 2019 Nov 21;76(4):546-561.e8
pubmed: 31561952
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5313-8
pubmed: 12702757
Nat Commun. 2022 Jul 29;13(1):4355
pubmed: 35906200
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
EMBO J. 1999 Nov 1;18(21):5943-52
pubmed: 10545106
Sci Transl Med. 2020 Dec 16;12(574):
pubmed: 33328331
Mol Cell Proteomics. 2014 Nov;13(11):2896-910
pubmed: 25106422
Oncotarget. 2017 May 22;8(43):73947-73963
pubmed: 29088759
Nat Rev Mol Cell Biol. 2018 Jan;19(1):4-19
pubmed: 28852220
Genes Dev. 2002 Jul 15;16(14):1779-91
pubmed: 12130538
J Biol Chem. 2003 May 30;278(22):20405-12
pubmed: 12660246
Oncogene. 2005 Sep 29;24(43):6564-73
pubmed: 16007186
Elife. 2017 Jan 16;6:
pubmed: 28079019
Cell. 2015 Feb 12;160(4):729-744
pubmed: 25679764
Curr Opin Struct Biol. 2008 Apr;18(2):236-42
pubmed: 18206362
Nature. 2015 Jan 29;517(7536):583-8
pubmed: 25494202
Mol Cell. 2016 Apr 7;62(1):63-78
pubmed: 27052732
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Nat Protoc. 2012 Sep;7(9):1728-40
pubmed: 22936215
Epigenetics Chromatin. 2019 Jul 12;12(1):42
pubmed: 31300027
Mamm Genome. 1996 Nov;7(11):803-9
pubmed: 8875887
EMBO Rep. 2002 Mar;3(3):224-9
pubmed: 11882541
Genes Dev. 1993 Apr;7(4):671-82
pubmed: 8458579
BMC Bioinformatics. 2010 Apr 01;11:165
pubmed: 20356413
Genome Biol. 2014;15(12):550
pubmed: 25516281
Mol Cell Biol. 2004 Jan;24(1):14-24
pubmed: 14673139
Nat Commun. 2017 Aug 15;8(1):255
pubmed: 28811569
Nat Cell Biol. 2016 May;18(5):527-39
pubmed: 27043084
Cancer Res. 2006 Apr 15;66(8):4065-78
pubmed: 16618726
EMBO J. 2011 Jan 19;30(2):249-62
pubmed: 21131905
Proc Natl Acad Sci U S A. 2020 Dec 29;117(52):33486-33495
pubmed: 33318173
Genes Dev. 2008 Oct 15;22(20):2755-66
pubmed: 18923074
Oncogene. 2007 Aug 2;26(35):5086-97
pubmed: 17310987
Oncogene. 2010 Sep 16;29(37):5204-13
pubmed: 20622894
Hum Genomics. 2019 Nov 7;13(1):54
pubmed: 31699156
Cold Spring Harb Symp Quant Biol. 2011;76:91-9
pubmed: 22371371
Nat Rev Cancer. 2015 Oct;15(10):593-607
pubmed: 26383138
Annu Rev Biochem. 2011;80:1089-115
pubmed: 21417720
Cell. 2007 Sep 21;130(6):1005-18
pubmed: 17889646
J Clin Invest. 2012 Oct;122(10):3742-54
pubmed: 22945628
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560
pubmed: 31114875
Cell. 2007 Jul 13;130(1):77-88
pubmed: 17632057
Cell Metab. 2011 Jul 6;14(1):91-103
pubmed: 21723507
Nat Commun. 2017 Nov 21;8(1):1638
pubmed: 29158484
Biochim Biophys Acta. 2014 May;1839(5):395-405
pubmed: 24705139
Philos Trans R Soc Lond B Biol Sci. 2011 Aug 12;366(1575):2198-207
pubmed: 21727125
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Cancer Res. 2019 Oct 15;79(20):5233-5244
pubmed: 31409638
Blood Adv. 2018 Aug 28;2(16):2039-2051
pubmed: 30115641
Cell. 2012 Mar 30;149(1):22-35
pubmed: 22464321
Stem Cell Reports. 2018 Jan 9;10(1):287-299
pubmed: 29249668
Cancer Res. 2009 Oct 1;69(19):7487-90
pubmed: 19773445
Mol Cell Biol. 1999 Jan;19(1):1-11
pubmed: 9858526
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6958-62
pubmed: 1495986
Cold Spring Harb Perspect Med. 2014 Jan 01;4(1):a020990
pubmed: 24384817
EMBO J. 2021 May 17;40(10):e105464
pubmed: 33792944
Genes Dev. 2016 Sep 15;30(18):2062-2075
pubmed: 27688402
Cold Spring Harb Perspect Med. 2014 Apr 01;4(4):a014373
pubmed: 24692190
EMBO J. 2015 Feb 3;34(3):275-93
pubmed: 25425574
Nat Biotechnol. 2014 Sep;32(9):896-902
pubmed: 25150836
Blood. 2000 Mar 15;95(6):2104-10
pubmed: 10706881
Science. 1991 Mar 8;251(4998):1211-7
pubmed: 2006410
Mol Cell Biol. 2000 Jan;20(2):556-62
pubmed: 10611234
BMC Genomics. 2012 Aug 24;13:424
pubmed: 22920947
Breast Cancer Res Treat. 2015 Aug;153(1):57-66
pubmed: 26223813

Auteurs

Meng Xu (M)

Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.

Ling Lin (L)

Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.

Babul Moni Ram (BM)

Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.

Omprakash Shriwas (O)

Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.

Kun-Han Chuang (KH)

Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.

Siyuan Dai (S)

Morningside Graduate School of Biomedical Sciences, UMass Chan Medical School, Worcester, MA 01605, USA.

Kuo-Hui Su (KH)

Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.

Zijian Tang (Z)

Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.

Chengkai Dai (C)

Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA. Electronic address: chengkai.dai@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH